| 000 | 01660 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513072757.0 | ||
| 264 | 0 | _c19930810 | |
| 008 | 199308s 0 0 eng d | ||
| 022 | _a0277-3732 | ||
| 024 | 7 |
_a10.1097/00000421-199308000-00012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGonzález-Manzano, R | |
| 245 | 0 | 0 |
_aPhase II evaluation of doxorubicin, ifosfamide, and dacarbazine plus amphotericin B in the treatment of metastatic soft tissue sarcomas. A pilot study. _h[electronic resource] |
| 260 |
_bAmerican journal of clinical oncology _cAug 1993 |
||
| 300 |
_a332-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmphotericin B _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aDacarbazine _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIfosfamide _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aSarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aSoft Tissue Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aVieitez, J M | |
| 700 | 1 | _aTangco, E | |
| 700 | 1 | _aFernandez de Alava, E | |
| 700 | 1 | _aHerranz, P | |
| 700 | 1 | _aGarcia-Foncillas, J | |
| 773 | 0 |
_tAmerican journal of clinical oncology _gvol. 16 _gno. 4 _gp. 332-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000421-199308000-00012 _zAvailable from publisher's website |
| 999 |
_c8327691 _d8327691 |
||